A group of shareholders in digital bank Monzo reportedly want to reinstate its outgoing CEO.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions .Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.TS Anil is due to step down as head of the U.K. company in February, but t ...

Here are two stocks with buy rank and strong value characteristics for investors to consider today, Dec. 17:Bread Financial Holdings, Inc. (BFH) : This U.S.-based tech-forward financial services company that provides payment and lending solutions carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 22.2% over the last 60 days.Bread Financial has a price-to-earnings ratio (P/E) of 7.30, compared with 12.30 for the industry. The company possesses a V ...

HDFC Bank has received approval from India’s central bank, the Reserve Bank of India (RBI), for its subsidiaries to acquire up to a 9.5% stake in IndusInd Bank. The approval has been given to HDFC units, HDFC Mutual Fund, HDFC Life Insurance, HDFC ERGO General Insurance, HDFC Pension Fund Management, and HDFC Securities. These units are allowed to jointly purchase up to 9.5% of IndusInd Bank’s paid-up share capital or voting rights, within one year, until 14 December 2026. According to a report from Ko ...

Core Insights - Amazon is reportedly in discussions to invest approximately $10 billion in OpenAI, which could value the AI startup at over $500 billion [2][3] - OpenAI is preparing for an initial public offering (IPO) that could value the company at up to $1 trillion [3] - The investment discussions highlight OpenAI's ability to expand its partnership base after transitioning from its non-profit origins and finalizing its deal with Microsoft [4] Investment Details - The potential investment from Amazon may lead to a larger funding round involving other investors [2] - Amazon aims to utilize its Trainium chips, which compete with Nvidia and Google's offerings, in conjunction with OpenAI's technology [2] Strategic Partnerships - OpenAI is looking to sell an enterprise version of ChatGPT to Amazon, although it remains unclear if this includes integration into Amazon's shopping features [3] - The existing agreement with Microsoft grants exclusive intellectual property rights to OpenAI's technology until 2032, while allowing Microsoft to pursue artificial general intelligence (AGI) independently [5] Industry Trends - Companies are consolidating AI tools into unified platforms to support core workflows and manage operational complexities, marking a shift in enterprise AI adoption [6][7]

Nvidia stock rises Wednesday. But the chip maker faces an increasing number of rivals in the U.S. and China. ...

Bostic says Fed should pause rate cuts, Warner Bros. to tell shareholders to reject Paramount bid, Medline set to trade in IPO, and more news to start your day. ...

Sign in to access your portfolio Sign in ...

Core Insights - The U.S. automotive industry is experiencing a shift away from fully electric vehicles (EVs), as evidenced by Ford's recent announcement to scale back its EV-focused business strategy, including scrapping plans for a new electric truck and converting its F-150 Lightning to a hybrid model [1][2][9] Industry Challenges - Manufacturing costs for vehicles in the U.S. have risen due to higher labor costs, stricter environmental regulations, and supply chain issues, leading to increased investment risk [4][5] - Regulatory changes and the elimination of federal tax credits for EVs have added uncertainty to investment decisions in U.S. manufacturing [5][6] - Ford's flagship EV, the F-150 Lightning, has faced profitability issues, with the cost of production rising significantly from an initial price of $40,000 to around $55,000 for the 2025 model [6][7] Market Dynamics - Despite record-high EV sales in the U.S. this year, the market is still heavily influenced by consumer sentiment, which has shown signs of decline, particularly among gas and hybrid vehicle drivers [15][16] - The global EV market is dominated by China, which accounts for approximately 70% of global EV production, highlighting the competitive challenges faced by U.S. automakers [11][12] Future Outlook - While Ford is scaling back on larger electric vehicles, it plans to focus on smaller, more affordable models and expand its hybrid offerings [10][19] - Experts remain optimistic about the long-term potential of EVs, citing advancements in battery technology and the overall positive experience of EV ownership [18][19] - The U.S. EV industry has faced fluctuations before, and while current economic conditions may justify a pullback, there is a risk of falling behind when the market rebounds [20]

Core Insights - Protalix BioTherapeutics and Secarna Pharmaceuticals have entered into a collaboration and option agreement to develop antisense oligonucleotide therapies for rare renal diseases, leveraging Protalix's expertise in rare diseases and Secarna's AI-powered OligoCreator platform [1][2][3] Company Overview - Protalix BioTherapeutics focuses on innovative therapeutics for rare diseases and has developed two enzyme replacement therapies available in multiple markets, utilizing a proprietary plant cell-based expression system called ProCellEx [4][5] - Secarna Pharmaceuticals specializes in oligonucleotide therapeutics and employs its OligoCreator platform to rapidly generate high-quality antisense candidates, aiming to transform untreatable conditions into treatable ones [7] Collaboration Details - The collaboration involves Protalix selecting pharmaceutical targets for rare renal indications, while Secarna will use its OligoCreator platform to design and profile ASO candidates against these targets [2] - Protalix has the option for an exclusive, worldwide license to further develop and commercialize the therapeutic programs resulting from this collaboration [2][3] Strategic Goals - The partnership aims to advance programs from preclinical stages to clinical trials, addressing significant unmet medical needs in the rare kidney disease space [2][3] - Both companies express excitement about the collaboration, highlighting the combination of Secarna's rapid candidate generation and Protalix's experience in bringing therapies to market [3]

Core Viewpoint - Sealed Air Corporation has entered into a definitive agreement with CD&R for an acquisition valued at $10.3 billion, with a purchase price of $42.15 per share, and the transaction is expected to close in mid-2026 [1][4]. Group 1: Transaction Details - The "go-shop" period for Sealed Air's acquisition expired on December 16, 2025, during which the company solicited alternative acquisition proposals from 29 parties, resulting in six parties entering confidentiality agreements [2]. - Following the expiration of the "go-shop" period, Sealed Air is now subject to "no-shop" provisions, limiting its ability to negotiate with third parties [3]. - The transaction is contingent upon stockholder approval, regulatory clearances, and other customary closing conditions [4]. Group 2: Company Overview - Sealed Air Corporation is a global leader in packaging solutions, generating $5.4 billion in sales in 2024 and employing approximately 16,400 people across 117 countries [6]. - The company specializes in food and protective packaging solutions, with well-known brands including CRYOVAC®, SEALED AIR®, LIQUIBOX®, AUTOBAG®, and BUBBLE WRAP® [6].